Should we rename low risk cancers?
Should we rename low risk (“indolent”) cancers in a bid to reduce anxiety and harm…
Browsing: overtreatment
Is it time to remove the cancer label from low-risk conditions?
Brooke Nickel, University of Sydney Over the past few decades, our understanding of cancer has…
Active surveillance of lung subsolid nodules reduces unnecessary surgery and overtreatment
Subsolid nodules (SSN) can be considered a biomarker of lung cancer risk and should be…